CLOBETASOL PROPIONATE: Pharmaceutical manufacturers, suppliers, and wholesalers

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Alembic	CLOBETASOL PROPIONATE	clobetasol propionate	AEROSOL, FOAM;TOPICAL	215838	ANDA	Alembic Pharmaceuticals Limited	46708-707-31	1 CAN in 1 CARTON (46708-707-31) / 100 g in 1 CAN	2025-04-25
Alembic	CLOBETASOL PROPIONATE	clobetasol propionate	AEROSOL, FOAM;TOPICAL	215838	ANDA	Alembic Pharmaceuticals Limited	46708-707-50	1 CAN in 1 CARTON (46708-707-50) / 50 g in 1 CAN	2025-04-25
Alembic	CLOBETASOL PROPIONATE	clobetasol propionate	AEROSOL, FOAM;TOPICAL	215838	ANDA	Alembic Pharmaceuticals Inc.	62332-707-31	1 CAN in 1 CARTON (62332-707-31) / 100 g in 1 CAN	2022-04-21
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: February 19, 2026

This report details key suppliers of Clobetasol Propionate, a potent corticosteroid used in topical formulations. It examines supplier capabilities, geographic reach, regulatory standing, and recent market activity to inform R&D and investment decisions for pharmaceutical companies. The analysis focuses on suppliers capable of producing active pharmaceutical ingredients (APIs) meeting stringent global quality standards.

What is Clobetasol Propionate API?

Clobetasol propionate is a synthetic glucocorticosteroid with potent anti-inflammatory, antipruritic, and vasoconstrictive properties. Its primary application is in the topical treatment of severe inflammatory skin conditions unresponsive to less potent corticosteroids. These include psoriasis, eczema, lichen planus, and seborrheic dermatitis. The API is manufactured through complex chemical synthesis, requiring specialized expertise and adherence to Good Manufacturing Practices (GMP).

The global market for Clobetasol Propionate API is driven by the prevalence of dermatological disorders and the demand for effective treatment options. Key factors influencing market dynamics include patent expirations, the rise of generic drug manufacturing, and evolving regulatory landscapes.

Key Clobetasol Propionate API Suppliers

The following entities are identified as significant suppliers of Clobetasol Propionate API, based on their manufacturing capacity, regulatory approvals, and market presence.

Global Manufacturing Footprint

Several suppliers operate manufacturing facilities across different geographic regions, enabling them to serve diverse market needs and mitigate supply chain risks.

India: This region hosts a substantial number of API manufacturers, benefiting from lower production costs and established pharmaceutical infrastructure. Companies like Abbott India Limited, Divi's Laboratories Limited, and Dr. Reddy's Laboratories are key players.
China: China is a major global supplier of APIs, including Clobetasol Propionate, due to its large-scale production capabilities and competitive pricing. Manufacturers such as Hubei Biocause Pharmaceutical Co., Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. are active in this space.
Europe: European suppliers often emphasize high-quality standards and regulatory compliance, catering to markets with strict oversight. BASF SE and Sanofi have historically been involved in API production or sourcing.

The geographic distribution of suppliers provides pharmaceutical companies with options for sourcing, price negotiation, and supply chain diversification.

Regulatory Compliance and Certifications

Suppliers must demonstrate adherence to international regulatory standards to ensure the quality and safety of their API. Key certifications and regulatory approvals include:

US Food and Drug Administration (FDA) Approval: Crucial for supplying to the U.S. market. Facilities are regularly inspected.
European Medicines Agency (EMA) Compliance: Necessary for access to the European Union market.
Good Manufacturing Practices (GMP): A fundamental requirement by regulatory bodies worldwide, ensuring consistent production and quality control.
Written Confirmation (WC) for Export: Required by the EMA for APIs exported from countries without equivalent regulatory oversight.

Companies that consistently maintain these certifications are typically more reliable partners. For instance, a supplier with a long history of successful FDA inspections indicates a robust quality management system.

Manufacturing Capacity and Technology

The ability of a supplier to consistently meet demand hinges on their manufacturing capacity and the technology employed.

Production Volume: Large-scale reactors and dedicated production lines are indicative of significant capacity. Suppliers often disclose production capacities in technical documentation or through direct engagement.
Synthesis Routes: The specific chemical synthesis route used can impact purity, yield, and cost. Proprietary or optimized synthesis pathways can provide a competitive advantage.
Quality Control Systems: Advanced analytical instrumentation (e.g., HPLC, GC-MS) and stringent in-process testing are essential for API purity and conformity to pharmacopoeial standards (USP, EP, JP).

Companies investing in continuous process improvement and advanced analytical technologies are better positioned to deliver high-quality Clobetasol Propionate API.

Market Dynamics and Supplier Landscape

The Clobetasol Propionate API market is characterized by several factors influencing supplier selection and market strategy.

Competition and Pricing

The market is moderately competitive, with a mix of large, established players and smaller specialized manufacturers. Pricing is influenced by:

Raw Material Costs: Fluctuations in the prices of precursor chemicals directly impact API production costs.
Manufacturing Efficiency: Suppliers with optimized processes and economies of scale can offer more competitive pricing.
Regulatory Burden: The cost associated with maintaining compliance with evolving global regulations can be passed on to customers.
Volume Commitments: Larger purchase volumes often lead to more favorable pricing structures.

For example, a supplier in India might offer a 10-15% lower price per kilogram compared to a European supplier for a similar quality API, due to differences in labor and overhead costs.

Supply Chain Reliability and Risk Mitigation

Ensuring a consistent and uninterrupted supply of Clobetasol Propionate API is critical for pharmaceutical product manufacturing. Key considerations for supply chain reliability include:

Dual Sourcing: Pharmaceutical companies often seek to qualify multiple suppliers to mitigate risks associated with single-source dependency.
Geopolitical Stability: The political and economic stability of the supplier's operating region can impact supply continuity.
Logistics and Transportation: Efficient and secure transportation networks are vital for timely delivery.
Inventory Management: Suppliers with robust inventory management systems are better equipped to meet urgent demand.

A supplier's ability to provide supply chain transparency and implement contingency plans for disruptions (e.g., natural disasters, trade restrictions) is a significant advantage.

Recent Market Trends and Developments

Recent trends in the Clobetasol Propionate API market include:

Increased Scrutiny on Impurities: Regulatory bodies are placing greater emphasis on controlling and reporting impurities, including genotoxic impurities. Suppliers must have sophisticated impurity profiling and control strategies.
Focus on Sustainability: Environmental, Social, and Governance (ESG) factors are becoming more important in supplier selection. Companies are looking for suppliers with demonstrable commitments to sustainable manufacturing practices.
Technological Advancements: Innovations in chemical synthesis, such as continuous flow chemistry or biocatalysis, are being explored to improve efficiency and reduce environmental impact.

These trends necessitate ongoing due diligence and collaboration between API purchasers and their suppliers.

Supplier Profiles

Detailed profiles of select key suppliers are presented below, highlighting their core strengths and market positioning.

Abbott India Limited

Region: India
Key Strengths: Extensive manufacturing experience, strong regulatory track record with FDA and EMA, diversified product portfolio, robust quality control systems.
Market Position: A well-established player in the Indian API market, known for consistent quality and reliability. They serve both domestic and international markets.
Regulatory Standing: Holds numerous GMP certifications and has a history of successful regulatory inspections.

Divi's Laboratories Limited

Region: India
Key Strengths: Large-scale API manufacturing capacity, expertise in complex chemistry, strong focus on process optimization, and backward integration for key raw materials.
Market Position: One of the largest API manufacturers globally, known for its efficiency and competitive pricing. A significant supplier of corticosteroids.
Regulatory Standing: Compliant with major global regulatory authorities, including US FDA, EMA, and PMDA (Japan).

Hubei Biocause Pharmaceutical Co., Ltd.

Region: China
Key Strengths: Significant production volume, competitive pricing, established presence in the global API market.
Market Position: A major Chinese API producer with a broad range of products. Focuses on cost-effective manufacturing for high-volume generics.
Regulatory Standing: Holds various GMP certifications and aims to meet international standards for its export markets.

Zhejiang Huahai Pharmaceutical Co., Ltd.

Region: China
Key Strengths: Strong R&D capabilities for process development, large-scale manufacturing, focus on quality and regulatory compliance.
Market Position: A leading Chinese pharmaceutical company with a strong international presence in API supply. Known for its investment in advanced manufacturing technologies.
Regulatory Standing: Holds approvals from major regulatory agencies including US FDA, EMA, and KFDA (Korea).

BASF SE

Region: Germany (Global operations)
Key Strengths: Global chemical giant with extensive expertise in chemical synthesis and quality management. Strong emphasis on innovation and sustainability.
Market Position: While primarily a chemical company, BASF has historically been involved in the pharmaceutical supply chain, often through specialized intermediates or custom synthesis. Their involvement in Clobetasol Propionate API supply would likely be through their fine chemicals division.
Regulatory Standing: Adheres to the highest international quality and regulatory standards across its operations.

Strategic Considerations for Pharmaceutical Companies

When selecting Clobetasol Propionate API suppliers, pharmaceutical companies should consider the following strategic factors:

Quality Assurance and Control

Auditing: Conduct rigorous on-site audits of potential suppliers' manufacturing facilities and quality management systems.
Specifications: Ensure API specifications meet or exceed pharmacopoeial requirements and internal quality standards. Pay close attention to impurity profiles.
Change Control: Establish clear protocols for managing and approving any changes in the supplier's manufacturing process, equipment, or raw materials.
Traceability: Verify that suppliers maintain complete traceability of raw materials and finished API batches.

Supply Chain Management

Lead Times: Understand and negotiate realistic lead times for API delivery.
Buffer Stock: Maintain adequate buffer stock of API to mitigate the impact of unforeseen supply disruptions.
Contractual Agreements: Develop robust supply agreements that clearly define quality standards, delivery schedules, pricing, and responsibilities.
Risk Assessment: Regularly assess and update risk assessments for critical suppliers, considering geopolitical, economic, and operational factors.

Cost Optimization

Total Cost of Ownership: Evaluate not only the per-kilogram price but also associated costs such as shipping, import duties, quality control testing, and potential risks of supply disruption.
Long-Term Partnerships: Explore opportunities for long-term contracts with preferred suppliers, which can lead to volume discounts and greater supply security.
Market Intelligence: Continuously monitor market prices and competitor activities to ensure competitive sourcing.

Innovation and Future-Proofing

R&D Collaboration: Engage with suppliers who demonstrate a commitment to R&D and are willing to collaborate on process improvements or next-generation API manufacturing techniques.
Regulatory Landscape Monitoring: Work with suppliers who actively monitor and adapt to evolving global regulatory requirements.
Sustainability Initiatives: Prioritize suppliers who align with corporate sustainability goals and demonstrate responsible manufacturing practices.

Key Takeaways

The Clobetasol Propionate API market is served by a diverse range of global suppliers, primarily based in India and China, with additional presence in Europe. Key considerations for pharmaceutical companies include stringent adherence to regulatory standards (FDA, EMA, GMP), robust quality control systems, manufacturing capacity, and supply chain reliability. Pricing is influenced by manufacturing efficiency, raw material costs, and volume. Strategic sourcing involves rigorous supplier auditing, clear contractual agreements, risk mitigation through dual sourcing, and continuous market monitoring. Emerging trends such as increased impurity scrutiny and a focus on sustainability are shaping the supplier landscape.

Frequently Asked Questions

What are the primary quality standards that Clobetasol Propionate API suppliers must meet? Suppliers must meet pharmacopoeial standards such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and Japanese Pharmacopoeia (JP). Compliance with Good Manufacturing Practices (GMP) is mandatory, and approvals from regulatory bodies like the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are essential for access to major markets.
How can pharmaceutical companies ensure the long-term reliability of their Clobetasol Propionate API supply? Reliability can be ensured through dual sourcing from multiple qualified suppliers, maintaining strategic buffer stock, establishing robust contractual agreements that define service levels and contingency plans, and conducting ongoing risk assessments of geopolitical and operational factors affecting suppliers.
What is the typical impact of raw material cost fluctuations on Clobetasol Propionate API pricing? Fluctuations in the cost of key precursor chemicals used in the synthesis of Clobetasol Propionate API can directly impact production costs. Suppliers may pass these increases on to customers, leading to higher API prices. Conversely, a decrease in raw material costs can result in more competitive API pricing.
What role do impurity profiles play in the selection of Clobetasol Propionate API suppliers? Impurity profiles are critical. Regulatory bodies have increased scrutiny on the control of impurities, including potentially genotoxic ones. Suppliers must demonstrate sophisticated impurity profiling capabilities, robust control strategies to minimize impurities to acceptable levels, and transparent reporting of any identified impurities to meet regulatory requirements.
Are there any significant trends in Clobetasol Propionate API manufacturing that pharmaceutical companies should be aware of? Emerging trends include a greater focus on sustainability and ESG factors in supplier selection, with companies seeking partners committed to environmentally responsible manufacturing. Additionally, advancements in chemical synthesis technologies, such as continuous flow chemistry, are being explored to enhance efficiency, reduce waste, and improve product quality.

Citations

[1] World Health Organization. (2020). Good Manufacturing Practices for Pharmaceutical Products. https://www.who.int/teams/regulation-quality-and-innovation/pharmaceuticals/good-manufacturing-practices [2] U.S. Food & Drug Administration. (n.d.). Inspections, Compliance, Enforcement, and Recalls. https://www.fda.gov/inspections-compliance-enforcement-and-recalls [3] European Medicines Agency. (n.d.). Inspections and Good Manufacturing Practice. https://www.ema.europa.eu/en/human-regulatory/inspections-good-manufacturing-practice [4] United States Pharmacopeia. (n.d.). USP-NF Online. https://www.uspnf.com/ [5] European Directorate for the Quality of Medicines & HealthCare. (n.d.). EDQM. https://www.edqm.eu/ [6] Divi's Laboratories Limited. (2023). Annual Report 2022-2023. [Retrieved from company website investor relations section] [7] Zhejiang Huahai Pharmaceutical Co., Ltd. (2023). Annual Report 2022. [Retrieved from company website investor relations section]

Suppliers and packagers for CLOBETASOL PROPIONATE